DBCO-PEG2-acid - ≥97%

Cat. No.: D597077
AVAILABLE TO ORDER
GRADE & PURITY ≥97%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
Application
227,228,229
★
Size
USA
Germany (EU)*
Price
Qty
25mg
D597077-25mg
Made to order · 8–12 wks
$714.90
100mg
D597077-100mg
Made to order · 8–12 wks
$1,596.90
250mg
D597077-250mg
Made to order · 8–12 wks
$3,570.90
Enter a quantity for the sizes you want to add.

Overview

DBCO-PEG2-acid is an analog of DBCO-Acid with PEG linker and a DBCO group. The DBCO groups is commonly used for copper-free Click Chemistry reactions due to its strain promoted high energy. The hydrophilic PEG chain allows for increased water solubility. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.

Specifications

Specifications & Purity
≥97%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Purity
≥97%

Advanced Data

Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Documents & Articles
Solution Calculators
Reviews

Customer Reviews

Application Protocols

The following general protocols are provided as literature-style guidance and should be optimized for your system. They are not validated, item-specific methods.

  • Protocol A: Installing DBCO onto an amine-bearing peptide (amide coupling)

    1. Dissolve peptide (free amine) in dry DMF (or 80% DMF/20% water) at 1–5 mM.
    2. In a separate vial, dissolve DBCO-PEG2-acid (1.2 eq) and HATU (1.3 eq) in dry DMF; add DIPEA (3 eq); pre-activate 5–10 min.
    3. Combine solutions; react 1–2 h at RT. Monitor by LC–MS.
    4. Quench with water, purify by RP-HPLC, and lyophilize. Confirm by MS and analytical HPLC.
  • Protocol B: SPAAC labeling of an azide-modified protein

    1. Prepare protein in PBS (pH 7.4) at 1–10 µM. Ensure azide installation (e.g., via NHS–azide or metabolic labeling).
    2. Add DBCO-PEG2-acid stock in DMSO to 10–50 µM final (≤5% DMSO). Incubate 1–2 h at RT (or 4°C overnight).
    3. Remove excess reagent by desalting column (e.g., Sephadex G-25) or dialysis.
    4. Analyze by SDS-PAGE and intact-protein MS.
  • Protocol C: Aqueous EDC/NHS activation to form DBCO-PEG2–NHS ester in situ

    1. Dissolve DBCO-PEG2-acid in MES (pH 5.5) with 10–20% DMSO at 5–20 mM.
    2. Add EDC (1.5 eq) and NHS (1.5 eq), stir 15–20 min at RT.
    3. Transfer to amine-containing substrate in phosphate buffer (pH 7.4), react 1–2 h.

Note: For sensitive biomolecules, minimize organic content and verify compatibility. Always perform small-scale trials.

Biological Roles

DBCO-PEG2-acid is a synthetic chemical tool and has no native biological role. Its relevance in biochemistry arises from its use as a bioconjugation handle enabling selective, bioorthogonal ligations under mild conditions.

  • Bioorthogonal chemistry (literature context):

    • SPAAC between DBCO and azides proceeds in complex biological media without catalysts, enabling labeling of azide-functionalized glycans, lipids, nucleic acids, or proteins introduced via metabolic incorporation or chemical modification.
    • The short PEG2 spacer can reduce nonspecific hydrophobic interactions relative to non-PEG DBCO, while maintaining compact size for minimal perturbation of biomolecules.
  • Compatibility considerations:

    • Operates at physiological pH and temperature; tolerates salts and most common buffers. High concentrations of thiols (e.g., free cysteine, DTT) may compete via side reactions with strained alkynes in some systems—optimize conditions accordingly.
    • Copper-free conditions avoid catalyst-related oxidative damage observed in CuAAC on sensitive biomolecules.
  • Analytical follow-up:

    • Resulting triazole linkages are chemically stable, facilitating downstream purification (SEC, HIC) and analysis (LC–MS, SDS-PAGE with azide-fluorophore tags).

Note: This product is for research use only and is not intended for diagnostic or therapeutic applications.

Buffer Applications

DBCO-PEG2-acid is not a buffering agent. However, buffer choice is critical to its use in bioconjugation and amide-coupling workflows.

  • SPAAC conditions (general guidance):

    • Preferred buffers: PBS, HEPES, or phosphate buffer, pH 6.8–7.8.
    • Organic cosolvent: 0–20% DMSO or DMF to maintain clarity of DBCO stocks upon dilution.
    • Salt: Physiological ionic strength (100–200 mM NaCl) is typically compatible.
  • EDC/NHS coupling of the –CO2H (aqueous route):

    • Activation buffer: MES or acetate buffer, pH 5.0–6.0 to favor O-acylisourea/NHS-ester formation.
    • Coupling buffer: Phosphate or HEPES, pH 7.2–8.0 after activation for reaction with primary amines.
    • Avoid: Tris, glycine, or other amine-containing buffers during activation/coupling as they can quench activated esters.
  • Practical recipes (illustrative, scale accordingly):

    • Activation: Dissolve DBCO-PEG2-acid in 10–20% DMSO/MES (50 mM, pH 5.5), add EDC (1.1–2.0 eq) and NHS (1.1–2.0 eq), 15–30 min at RT.
    • Coupling: Transfer to amine-bearing target in phosphate buffer (pH 7.4), final organic ≤10%, react 1–2 h at RT.

These are general literature practices; optimize to your system and consult the product’s CoA/SDS for any item-specific constraints.

Green Alternatives

DBCO-PEG2-acid already enables copper-free click chemistry, avoiding copper salts and associated cytotoxicity and waste. Greener choices focus on solvent selection and alternative handles where appropriate.

  • Greener solvent strategies (literature guidance):

    • Favor water-rich systems with minimal DMSO/DMF co-solvent for SPAAC.
    • When conducting amide couplings, consider 2-MeTHF or propylene carbonate as partial replacements for DMF/MeCN when solubility allows; pre-dissolve in a small volume of DMSO if needed.
    • Employ aqueous EDC/NHS coupling (MES buffer, pH 5.0–6.0) to avoid strictly anhydrous organic media.
  • Alternative click partners (contextual):

    • BCN- or DIBO-based cyclooctynes can provide comparable SPAAC reactivity; selection may be guided by rate constants, stability, and cost. However, DBCO is widely used and well-characterized.
  • Tradeoffs to consider:

    • Replacing DMF with greener solvents may reduce solubility or coupling rates; pilot tests are advised.
    • Longer PEG linkers (e.g., PEG4–PEG12) can improve aqueous handling, but may increase molecular mass and hydrophilicity, affecting permeability and downstream analytics.
  • Summary comparison (informational):

    • DMSO (benchmark): Excellent solubility; readily biodegradable; acceptable toxicity profile at low %; high boiling point complicates removal.
    • 2-MeTHF: Renewable, lower toxicity than THF; limited polarity for some DBCO-PEG acids.
    • Water/MES buffer: Greenest medium for EDC/NHS activation; ensure reagent remains in solution with 5–10% DMSO.
Pharmaceutical Uses

This product is for research use only. It is not intended for human or veterinary use, clinical diagnostics, or as an active pharmaceutical ingredient.

  • Formulation/manufacturing context (general, non-clinical):

    • Conjugation handle: The DBCO motif is widely used in process development for site-selective attachment to azide-functionalized intermediates (e.g., polymers, peptides) via SPAAC under metal-free conditions.
    • Linker engineering: The PEG2–acid terminus enables installation onto primary amine-bearing substrates through amide bonds, creating DBCO-tagged constructs for subsequent assembly steps.
    • Analytical development: Stable triazoles formed after SPAAC aid in method validation (HPLC/LC–MS) during scale-up and characterization of conjugates.
  • Excipient status: No pharmacopeial excipient monograph is associated with this specific reagent (general note). Any use in GMP settings would require internal qualification, impurity profiling, and residual solvent controls.

  • Handling considerations for process R&D:

    • Choose solvent systems that preserve target integrity (avoid high % organic with labile proteins/peptides).
    • Control residual DMSO/DMF by workup or diafiltration as applicable.
    • Implement orthogonal assays (UV, MS) to quantify unreacted DBCO and ensure complete azide consumption prior to downstream steps.

All statements above relate to research and development workflows and do not imply therapeutic or clinical application.

Physical Properties
  • Item-specific properties from Product Data:

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Typical/literature expectations (informational, not item specifications):

    • Physical state: Usually an off-white to pale solid for DBCO–PEG–acid derivatives.
    • Solubility: Good solubility in polar aprotic solvents (DMSO, DMF, NMP) and mixed aqueous buffers when aided by co-solvent; limited solubility in pure water due to hydrophobic DBCO core; improved relative to non-PEG DBCO.
    • Acid functionality: Carboxylic acid pKa typically ~4–5 (literature; actual value depends on linker and microenvironment).
    • LogP/logD: Amphiphilic; overall lipophilicity reduced by PEG2; exact values vary by substitution (literature, not specified for this item).
    • Optical: DBCO absorbs in the near-UV; weak tail into visible; used for monitoring by HPLC-UV around 254 nm (literature guidance).
    • Melting point/boiling point/density/refractive index: Not commonly reported for this class of bioconjugation reagents; not specified for this item.
  • Practical notes:

    • Prepare stock solutions in anhydrous DMSO or DMF to defined concentrations (e.g., 10–50 mM) for reproducible dosing.
    • In aqueous systems, employ 5–20% DMSO or DMF as a cosolvent if needed; mild warming and brief sonication can aid dissolution.
    • Avoid strong bases and strong acids for prolonged periods to minimize side reactions (e.g., hydrolysis/isomerization).
Quality & Grades
  • Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

  • Typical quality considerations for DBCO-PEG bioconjugation reagents (general guidance):

    • Purity characterization: Vendors commonly verify by HPLC (>90–95% area, literature norms), 1H/13C NMR, and HRMS. Low residual solvents and controlled water content improve coupling reliability.
    • Identity control: Mass spectrometry confirmation of [M+H]+ and [M−H]− signals; IR shows alkyne C≡C stretch and carbonyl C=O of the carboxylic acid.
    • Functional integrity: SPAAC reactivity depends on intact strained alkyne; monitor by test-click with a model azide under standardized conditions to confirm activity.
    • Stabilizers: None are typically added to DBCO-PEG acids; if present, they should be disclosed on the CoA. For this item, stabilizers are not specified.
    • UV profile: Reasonably low baseline in the visible; measurable at 254 nm aids in HPLC tracking; HPLC-grade solvents during QC reduce baseline noise (general note).
  • What the grade means (general definitions):

    • “Bioconjugation” or “Click-ready” grade often implies high chemical purity, low inorganic residues, and verification of reactive handle performance. Analytical reagent (AR) or technical grades may be insufficient for sensitive biomolecule coupling due to trace impurities.

For precise specifications applicable to SKU D597077, please consult the CoA/Spec Sheet associated with your lot.

Reaction & Applications

DBCO-PEG2-acid is a dual-function reagent combining a copper-free “click” alkyne with a carboxyl handle for covalent attachment to amines, enabling modular assembly and bioconjugation.

  • Primary application: SPAAC (Strain-Promoted Azide–Alkyne Cycloaddition)

    • Reacts rapidly and selectively with organic azides to form stable triazoles without Cu(I) catalyst (literature). Suitable for labeling azide-bearing biomolecules, polymers, surfaces, and nanoparticles.
    • Operates in purely aqueous media or mixed solvents at ambient temperature, accommodating delicate biomolecules.
  • Secondary application: Amide-bond formation via the –CO2H terminus

    • Activate with EDC/NHS (or HATU, TBTU) to couple to primary amines on peptides, proteins (lysines), dyes, or solid supports, installing a DBCO handle for subsequent SPAAC.
    • The short PEG2 spacer improves water compatibility and reduces steric hindrance versus direct aryl-carboxylates.
  • Additional uses (literature examples):

    • Surface functionalization: Grafting onto amine-terminated self-assembled monolayers or polymer films to create azide-clickable surfaces.
    • Sequential orthogonal ligations: Combine amide coupling (to install DBCO) with SPAAC (to attach azide payloads) while remaining orthogonal to thiol–maleimide chemistries.
    • Probe synthesis: Conjugation to amine-bearing fluorophores or affinity ligands to produce DBCO-tagged probes for azide-enabled capture.
  • Practical tips:

    • Minimize exposure to free azides in buffers unless they are intentional reaction partners.
    • For protein conjugation, optimize pH 7.0–7.4 for SPAAC; for acid activation, use pH 5.0–6.0 (EDC/NHS) to reduce O-acylisourea hydrolysis, then adjust to pH 7–8 for coupling.
Reaction Conditions

The following are general literature conditions for DBCO-azide SPAAC and for coupling the –CO2H terminus; they are not item-specific specifications.

  • SPAAC with azides (general):

    • Solvent: Aqueous buffers (PBS, HEPES) with 0–20% DMSO/DMF if needed.
    • Concentration: 1–1000 µM for biomolecule labeling; 1–50 mM for small-molecule synthesis.
    • Temperature: 20–25°C (room temperature) is typical; 4°C for sensitive proteins (slower kinetics), or 37°C for faster rates when compatible.
    • Stoichiometry: 1.2–5.0 equiv of DBCO-PEG2-acid (or the azide partner) depending on target density and desired conversion.
    • Kinetics: Second-order rate constants for DBCO–azide SPAAC are commonly in the 10−2–1 M−1 s−1 range depending on solvent and azide structure (literature).
    • Time: Minutes to a few hours for micromolar systems; monitor by LC–MS or SDS-PAGE/fluorescence for biomolecules.
  • Amide coupling of the carboxyl group:

    • Organic-phase route: DBCO-PEG2-acid (1.0 eq), HATU (1.1–1.5 eq), DIPEA (2–4 eq) in dry DMF or MeCN, 0–25°C, 0.5–4 h. Work up and purify by preparative HPLC if necessary.
    • Aqueous EDC/NHS route: MES buffer (50–100 mM, pH 5.0–6.0), EDC (1.1–2.0 eq), NHS (1.1–2.0 eq), 10–20 min activation; add to amine in phosphate buffer (pH 7.2–8.0) and react 1–2 h at RT.
    • Typical outcomes: High conversions for small molecules; for proteins, degree of labeling depends on lysine accessibility—optimize equivalents and time.
  • Notes:

    • Protect from strong light/oxidants; minimize air exposure for long incubations.
    • Validate by a small-scale pilot before scaling; confirm mass gains consistent with triazole/amide formation.
Safety & Handling
  • GHS classification and hazard statements (item-specific): Not specified for this item; refer to SDS for authoritative safety information.

  • Signal word/pictograms: Not specified for this item; refer to SDS.

  • General laboratory safety guidance (for DBCO-PEG carboxylic acids; informational only):

    • PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Handle powders and stock solutions in a fume hood to avoid inhalation/ingestion.
    • Irritation/sensitization: Organic acids and aromatic reagents may cause skin/eye irritation; rinse affected areas with water for ≥15 minutes. Seek medical attention if symptoms persist.
    • Incompatibilities: Avoid strong oxidizers and strong bases for extended times. Copper salts are not required for SPAAC; avoid unintended exposure to azide-containing materials to prevent uncontrolled consumption of reagent.
    • Special risks: Strained alkynes can undergo side reactions with nucleophiles (e.g., thiols) and ozone/oxidants; protect from strong UV and oxidizing atmospheres.
    • Hygiene: Prevent contact with skin and eyes; do not eat/drink in work area. Wash hands after handling.
    • Spill/cleanup: Absorb liquids on inert material; collect solids by gentle sweeping with minimal dust generation. Dispose in accordance with institutional and local regulations.
  • First aid overview (general):

    • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
    • Skin/eye contact: Rinse with water; remove contaminated clothing; get medical advice if irritation continues.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Always consult the SDS provided for this specific SKU for definitive hazard, exposure limits, and response measures.

Solvent Selection

DBCO-PEG2-acid is amphiphilic: the DBCO core is hydrophobic, while PEG2 and –CO2H impart some hydrophilicity. Solvent choice should balance solubility, stability, and downstream compatibility.

  • Polarity/miscibility (general, literature):

    • Highly soluble in polar aprotic solvents: DMSO, DMF, NMP, acetonitrile (moderate).
    • Limited solubility in pure water; often soluble in aqueous buffers with 5–20% DMSO/DMF or with surfactants/protein carriers.
    • Poor solubility in non-polar hydrocarbons; moderate in ethyl acetate and alcohols (MeOH/EtOH) depending on counter-ions and concentration.
  • Typical use scenarios:

    • Bioconjugation (aqueous): Prepare concentrated DMSO stock (e.g., 10–50 mM), then dilute into phosphate or HEPES buffer. Keep final organic content ≤10% if sensitive biomolecules are present.
    • Amide coupling (organic or mixed): Use dry DMF/DMSO/MeCN with EDC/HOBt or HATU; add a tertiary amine base (DIPEA) in anhydrous conditions.
  • Comparison and guidance:

    • DMSO: Maximum solubilizing power; biocompatible in small percentages; may reduce disulfides at high temps (rare in short exposures).
    • DMF: Excellent for coupling chemistry; less preferred for live-cell contexts; ensure low dimethylamine content for carbamate-sensitive targets.
    • MeCN: Good for preparative HPLC dissolution and some couplings; lower solubility than DMSO/DMF.
    • Aqueous buffers: SPAAC proceeds efficiently at neutral pH; include co-solvent for clarity. Avoid amine-rich buffers (e.g., Tris) during NHS ester coupling of the acid.
Storage & Reconstitution
  • Item-specific storage and shipping:

    • Storage Conditions: Store at −20°C (from Product Data).
    • Shipped In: Ice chest + ice pads (from Product Data).
  • General handling recommendations (informational):

    • Protect from light and moisture. Store in tightly closed, inert-atmosphere containers if possible (e.g., desiccator). Allow to warm to room temperature in a sealed container before opening to avoid condensation.
    • After opening, promptly prepare aliquots to minimize repeated freeze–thaw and headspace exposure.
  • Reconstitution guidance (general):

    • Solvents: Prepare concentrated stock solutions in anhydrous DMSO or DMF (e.g., 10–50 mM). Filter through 0.22 µm PTFE if particulate is present.
    • Aqueous use: Dilute stocks into buffer immediately before use; maintain final organic content appropriate for the system (typically ≤10%). Brief sonication may aid dissolution.
    • Stability: Activated esters (if generated) are transient—use immediately. The parent acid and DBCO core are generally stable under recommended storage; avoid prolonged exposure to strong bases/acids and oxidants.
  • Research Use Note: For research use only (from Product Data).

For definitive shelf-life, retest intervals, and any lot-specific precautions, consult the CoA/Spec Sheet and SDS for SKU D597077.

Structure & Identity

DBCO-PEG2-acid is a strain-promoted alkyne cycloaddition (SPAAC) handle based on a dibenzocyclooctyne (DBCO) core, appended via a short polyethylene glycol spacer (two ethylene glycol units) to a terminal carboxylic acid.

  • Item-specific identifiers:

    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general description, literature):

    • Core: A bicyclic/aromatic-fused cyclooctyne (dibenzocyclooctyne), a highly strained internal alkyne that reacts rapidly with organic azides without copper.
    • Linker: Short PEG spacer consisting of two –CH2–CH2–O– units (PEG2), imparting hydrophilicity and spacing from the reactive alkyne.
    • Terminus: A free carboxylic acid (–CO2H) for downstream activation (e.g., EDC/NHS) and amide-bond formation to amines on biomolecules, polymers, or surfaces.
    • Functional groups: Strained alkyne, ether linkages, aromatic rings, and a carboxylic acid (Bronsted acid, H-bond donor/acceptor).
    • Stereochemistry: None specified; typical DBCO scaffolds in PEG-acid derivatives are achiral or racemic at any saturated centers (literature).
  • 2D structure in words: Two fused benzene rings flank an eight-membered alkyne-containing ring (DBCO). From one aromatic ring, a short –O–CH2–CH2–O–CH2–CH2– chain terminates in –CO2H. The alkyne is internal and conjugated to the aromatic system, responsible for SPAAC reactivity.

Synthetic Utility

DBCO-PEG2-acid is a bifunctional building block that streamlines installation of a copper-free click handle onto diverse substrates, enabling convergent synthesis.

  • Functional groups and reactivity (general):

    • Strained alkyne (DBCO): Undergoes rapid [3+2] cycloaddition with organic azides (SPAAC), forming 1,2,3-triazoles without catalysts. Rate constants are substantially higher than unstrained alkynes.
    • Carboxylic acid: Amenable to standard coupling chemistry (EDC/NHS, HATU/DIPEA) to form amides with primary or secondary amines; esterification with alcohols under carbodiimide or Steglich conditions is also feasible.
    • PEG2 spacer: Improves solubility and spatial separation from conjugation sites, often enhancing reaction efficiency and biocompatibility.
  • Retrosynthetic value:

    • Facilitates late-stage diversification: First couple DBCO-PEG2-acid to an amine-bearing scaffold, then perform SPAAC with azide-functionalized payloads (dyes, probes, polymers) under mild conditions.
    • Orthogonality: Amide coupling is orthogonal to SPAAC, allowing sequential or one-pot strategies (with protected amines or staged activation).
  • Named/related transformations (literature):

    • SPAAC (Bertozzi-type copper-free click chemistry) with azides.
    • Carbodiimide-mediated amide coupling (EDC/NHS), uronium coupling (HATU, TBTU), or mixed anhydride methods for sensitive substrates.
  • Practical considerations:

    • Maintain anhydrous conditions during activation to minimize hydrolysis of active esters.
    • For polymer/solid-phase coupling, confirm loading via TNBS or colorimetric amine assays, then quantify installed DBCO by azide consumption or UV-Vis where applicable.
Target Specificity

Not applicable. This product is a small-molecule bioconjugation reagent, not an antibody or affinity reagent with defined biological target specificity.

  • Guidance: The SPAAC reaction partners are any organic azides introduced on biomolecules, polymers, or surfaces. Selectivity derives from the bioorthogonal chemistry rather than from molecular recognition.

  • Item-specific target/clone/isotype data: Not specified for this item; refer to CoA/Spec Sheet (not typically applicable).

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.